Cargando…

Personalised glucose therapy: glucose targets in critically ill patients with pre-existing poorly controlled type 2 diabetes

Detalles Bibliográficos
Autores principales:	Kar, P, Plummer, MP, Bellomo, R, Jenkins, AJ, Januszewski, AS, Lange, K, Chapman, MJ, Horowitz, M, Deane, AM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797823/ http://dx.doi.org/10.1186/2197-425X-3-S1-A290

Ejemplares similares

Nutrient-stimulated gallbladder emptying is incomplete during critical illness as assessed by 3D ultrasound
por: Plummer, MP, et al.
Publicado: (2015)

One-hour plasma glucose level after a 75 g oral glucose load and its relationship to gastric emptying in survivors of critical illness and stress hyperglycaemia
por: Jalleh, Ryan J., et al.
Publicado: (2023)

Study protocol and statistical analysis plan for the Liberal Glucose Control in Critically Ill Patients with Pre-existing Type 2 Diabetes (LUCID) trial
por: Poole, Alexis P., et al.
Publicado: (2023)

Withholding Stress Ulcer Prophylaxis To Mechanically Ventilated Enterally-Fed Critically Ill Patients Appears Safe: A Randomised Double-Blind Placebo Controlled Pilot Study
por: Selvanderan, SP, et al.
Publicado: (2015)

Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
por: Chapman, M, et al.
Publicado: (2011)

Comparative effects on glucose absorption of intragastric and post-pyloric nutrient delivery in the critically ill
por: Di Bartolomeo, Anna E, et al.
Publicado: (2012)

Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study
por: Kar, Palash, et al.
Publicado: (2015)

Glucose absorption and gastric emptying in critical illness
por: Chapman, Marianne J, et al.
Publicado: (2009)

Comparison of macroscopic abnormalities in patients receiving routine pantoprazole when compared to placebo
por: Summers, MJ, et al.
Publicado: (2015)

Fasting plasma glucose and glucose fluctuation are associated with COVID-19 prognosis regardless of pre-existing diabetes
por: Xie, Weijia, et al.
Publicado: (2021)

The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
por: Lee, Michael Y., et al.
Publicado: (2013)

Comparative Effects of Co-Ingesting Whey Protein and Glucose Alone and Combined on Blood Glucose, Plasma Insulin and Glucagon Concentrations in Younger and Older Men
por: Oberoi, Avneet, et al.
Publicado: (2022)

Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes
por: den Ouden, Henk, et al.
Publicado: (2016)

Ethnic disparities in insulin and glucose-dependent insulinotropic peptide (GIP) responses to intraduodenal glucose in health
por: Marathe, Chinmay S., et al.
Publicado: (2014)

Bench-to-bedside review: The gut as an endocrine organ in the critically ill
por: Deane, Adam, et al.
Publicado: (2010)

Does immunotoxicity of nanomaterials depend on the individual pre-existing conditions? A need for a personalised testing strategy
por: Boraschi, D., et al.
Publicado: (2021)

Is compromised intestinal barrier integrity responsible for the poor prognosis in critically ill patients with pre-existing hyperglycemia?
por: Wang, Yi-Feng, et al.
Publicado: (2022)

The therapeutic potential of a venomous lizard: the use of glucagon-like peptide-1 analogues in the critically ill
por: Deane, Adam M, et al.
Publicado: (2010)

Stress hyperglycaemia in critically ill patients and the subsequent risk of diabetes: a systematic review and meta-analysis
por: Ali Abdelhamid, Yasmine, et al.
Publicado: (2016)

Incretins and the intensivist: what are they and what does an intensivist need to know about them?
por: Plummer, Mark P, et al.
Publicado: (2014)

The impact of early hypoglycemia and blood glucose variability on outcome in critical illness
por: Bagshaw, Sean M, et al.
Publicado: (2009)

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
por: Zhu, Lihua, et al.
Publicado: (2020)

Stress Induced Hyperglycemia and the Subsequent Risk of Type 2 Diabetes in Survivors of Critical Illness
por: Plummer, Mark P., et al.
Publicado: (2016)

Acute Effects of Substitution, and Addition, of Carbohydrates and Fat to Protein on Gastric Emptying, Blood Glucose, Gut Hormones, Appetite, and Energy Intake
por: Giezenaar, Caroline, et al.
Publicado: (2018)

Pre-existing traits associated with Covid-19 illness severity
por: Ebinger, Joseph E., et al.
Publicado: (2020)

Morning glucose correlates poorly with daily mean glucose in cardiac surgical ICU patients: impact of ultradian variation of glucose
por: Hagg, D, et al.
Publicado: (2009)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Impact of gastric emptying to the glycemic and insulinemic responses to a 75‐g oral glucose load in older subjects with normal and impaired glucose tolerance
por: Trahair, Laurence G., et al.
Publicado: (2014)

Continuous prediction of glucose-level changes using an electronic nose in critically ill patients
por: Leopold, JH, et al.
Publicado: (2014)

Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients
por: Brunner, R, et al.
Publicado: (2010)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Blood glucose variability, measured as mean absolute glucose, strongly depends on the frequency of blood glucose level measurements
por: Harmsen, RE, et al.
Publicado: (2011)

PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013)

Accuracy of glucose measurements in critically ill patients
por: Claverie, V, et al.
Publicado: (2011)

Nutrition support practices in critically ill head injured patients: a global perspective
por: Costello, L, et al.
Publicado: (2015)

Point accuracy and reliability of an interstitial continuous glucose monitoring device in critically ill patients
por: Hooijdonk, R Van, et al.
Publicado: (2015)

Point and trend accuracy of continuous glucose monitoring using intravenous microdialysis in critically ill patients
por: Leopold, JH, et al.
Publicado: (2015)

Blood glucose and subcutaneous continuous glucose monitoring in critically ill horses: A pilot study
por: Vitale, Valentina, et al.
Publicado: (2021)

Glucose dysregulation in pre-clinical Alzheimer’s disease
por: Connolly, Niamh M. C., et al.
Publicado: (2019)

Effects of Age on Acute Appetite-Related Responses to Whey-Protein Drinks, Including Energy Intake, Gastric Emptying, Blood Glucose, and Plasma Gut Hormone Concentrations—A Randomized Controlled Trial
por: Giezenaar, Caroline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qqp38gus00vtr8e6dn7i3h4ovo